Mr. Danse was named President and CEO of Neurotech in 2005. He has 30 years of life science industry experience, with over 20 years in the ophthalmic industry. Previously he was President and CEO of the US ophthalmic pharmaceutical company ISTA Pharmaceuticals Inc. (NASDAQ: ISTA) and was responsible for taking the Company public in 2000. Mr. Danse also held various senior positions in Allergan where he was responsible for establishing a high-growth, profitable business operation in Japan and Asia, including several successful corporate acquisitions. His early career was spent in business development roles at Coopervision, Bausch & Lomb and Schering-Plough. He has also served as a director on the boards of several development-stage ophthalmic companies. Mr. Danse holds an MBA from Thunderbird School of Global Management in Glendale, Arizona.